Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07446153) titled 'A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects' on Feb. 26.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Condition:
Solid Tumor
Intervention:
Drug: HRS-8364 Tablet
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: March 2026
Target Sample Size: 282
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07446153
Published by HT Digital Cont...